In Conversation

When we interviewed you in 2010, you mentioned that “while Colombia has had a solid transformation of the health system in a short time, being a…

Ms. Dickens, in our interview with your Sanofi colleague Jan Hendrix in Belgium last month, he commented that it is amazing how diversified this company has…

Mrs van der Kamp, you launched your career as a strategy consultant however, since then you have moved into the pharmaceutical industry by joining Novartis where…

You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and…

Can you give us a sense of the history of this company and its Irish roots? The company started life in the UK and has always…

Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this…

Mr. Hynds, you were personally instrumental in leading the establishment of Actavis in Ireland in 2008. You commented at the time, ‘Historically, Actavis grew by acquisition…

Mr. Martin, you were appointed as Genzyme’s GM for UK and Ireland last month after having spent a decade at the organization. Robin Kenselaar, Head of…

With an expenditure of more than 10% of GDP on health, Belgium maintains one of the world’s leading healthcare systems. That said, could you please comment…

Dr De Backer looking into your background, we see that you have a background in aerospace engineering and applied biomedical computational fluid dynamics that is riddled…

Dr De Haes, as the CEO of ThromboGenics for the last five years, can you provide us with an overview of the company’s main achievements that…

October marks the completion of your first full year as general manager of Cegedim’s Belgian affiliate. To what extent do you feel that the skills you’ve…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here